Kim Raineri
Mr. Raineri is the Chief Technology Officer for Aspen Neuroscience, Inc. He is responsible for the Manufacturing, Supply Chain, Process and Analytical Development, Technology Development, and Delivery Device functions of a leading autologous iPSC derived cell therapy company targeting CNS diseases.
Prior to his position at Aspen, he was the Chief Manufacturing and Technology Officer for AVROBIO. He has also held various positions of responsibility in Cell and Gene Therapy Contract Manufacturing and Development Organizations (CDMO) as Vice President of Operations for Nikon CeLL innovation, Business Director for Lonza Bioscience Singapore Pte Ltd., and Director of Operations for Lonza Walkersville. Kim has a Master’s of Business Administration from Kennesaw State University and Bachelor’s of Science from the University of Miami.
-
19-Jan-2027Theatre 2Session 3: iPSCs – what does the future hold? Part 1
-
19-Jan-2027Theatre 2Session 4: iPSCs – what does the future hold? Part 2